2021 EUROTOX Virtual Congress Poster Presentation
HUB Organoids applications to drug safety and ADME evaluation
Poster 391: Intestinal organoids as in vitro model systems to assess safety and ADME properties of compounds
Discover our latest data on the application of HUB Organoids to the preclinical evaluation of a compound safety and ADME profile
Despite recent advances, safety, absorption, distribution, metabolism, and excretion (ADME) studies are often performed using traditional models such as cell lines, primary tissues, or animals. However, these models poorly mimic human physiology leading to adverse effects in clinical trials and compounds' attrition.
Download this poster to discover:
- Reduce costly traditional animal experiments and obtain a quick indication of your drug safety
- Use HUB Organoids™ for preclinical toxicity, metabolism, transport, and permeability assessment of your compounds
- Facts track your decision making at early stages of drug development.